INCARDA THERAPEUTICS, INC.

Profile

Company Names

INCARDA THERAPEUTICS, INC.

Addresses

39899 BALENTINE DRIVE, SUITE 185, NEWARK, CA 94560

150 NORTH HILL DRIVE #24, BRISBANE, CA 94005

150 POST STREET, SUITE 650, SAN FRANCISCO, CA 94108

150 POST STREET, SUITE 650, SAN FRANCSICO, CA 94108

228 HAMILTON AVENUE, 3RD FLOOR, PALO ALTO, X1 94301

Phone Numbers

408-219-2576
650-798-5000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$66,301,418.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2020-10-06 
$27,993,423.00 
$50,000,000.00 
$22,006,577.00 
Equity 
4
2017-10-20 
$35,296,018.00 
$42,127,033.00 
$6,831,015.00 
Equity 
3
2017-03-09 
$2,135,000.00 
$2,500,000.00 
$365,000.00 
Debt 
2
2013-09-03 
$566,977.00 
$12,900,000.00 
$12,333,023.00 
Equity 
1
2011-07-21 
$310,000.00 
$1,000,000.00 
$690,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ISAAC 
 
CHENG 
DIRECTOR
LIQUIDIA TECHNOLOGIES INC   |  BIOSCALE INC   |  EDISON PHARMACEUTICALS INC   |  ATREAON, INC.   |  SYNCHRONEURON INC.   |  AMYLYX PHARMACEUTICALS, INC.   |  TORPEDO DIAGNOSTICS, INC.   |  DNATRIX INC   |  ADJUVANCE TECHNOLOGIES INC.   |  INCARDA THERAPEUTICS, INC.   |  MEISSA VACCINES INC   |  TALLAC THERAPEUTICS, INC.   |  APNIMED, INC.   |  MEDRHYTHMS, INC.
JOHAN 
 
CHRISTENSON 
DIRECTOR
BENECHILL, INC.   |  HEALTHCAP VI, L.P.   |  NEXSTIM PLC   |  HEALTHCAP VII, L.P.   |  INCARDA THERAPEUTICS, INC.
GRACE 
 
COLON 
EXECUTIVE OFFICER, DIRECTOR
INTREXON CORP   |  INCARDA THERAPEUTICS, INC.   |  PERCEPTIMED, INC.   |  COCOON BIOTECH INC.   |  PARADIGM DIAGNOSTICS, INC.   |  VOYAGER THERAPEUTICS, INC.
ALAN 
 
COLOWICK 
DIRECTOR
NORA THERAPEUTICS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  VELOSBIO INC.   |  INCARDA THERAPEUTICS, INC.   |  SOLVE THERAPEUTICS, INC.   |  RECODE THERAPEUTICS, INC.   |  ANUMANA, INC.   |  HARPOON THERAPEUTICS, INC.   |  ALUMIS INC.
ANDREW 
 
ELBARDISSI 
DIRECTOR
NEOCHORD INC   |  CONVENTUS ORTHOPAEDICS INC   |  FARAPULSE, INC.   |  AXON THERAPIES INC.   |  INCARDA THERAPEUTICS, INC.   |  ELEMENT SCIENCE, INC.   |  REPRIEVE CARDIOVASCULAR, INC.   |  NXT BIOMEDICAL, LLC   |  AURION BIOTECH, INC.   |  ACUTUS MEDICAL, INC.   |  ADELA, INC.   |  MEDICAL MICROINSTRUMENTS, INC.
RANGACHARI 
 
NARASIMHAN 
EXECUTIVE OFFICER, DIRECTOR
INCARDA THERAPEUTICS, INC.
BISCHOFBERGER 
 
NORBERT 
DIRECTOR
INCARDA THERAPEUTICS, INC.
JOHN 
S. 
PATTON 
EXECUTIVE OFFICER, DIRECTOR
INCARDA THERAPEUTICS, INC.   |  AERAMI THERAPEUTICS HOLDINGS, INC.
MCCARTHY 
 
REENIE 
DIRECTOR
INCARDA THERAPEUTICS, INC.
MILLER 
 
SAMANTHA 
EXECUTIVE OFFICER
INCARDA THERAPEUTICS, INC.
CARLOS 
A. 
SCHULER 
EXECUTIVE OFFICER, DIRECTOR
INCARDA THERAPEUTICS, INC.
DAN 
 
WELCH 
DIRECTOR
INCARDA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-10-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-06 
2019-11-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-20 
2017-05-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2017-03-09 
2014-12-19
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-09-03 
2013-09-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-09-03 
2012-10-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2011-07-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#